相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Whole-genome sequencing of East Asian lung cancers reveals new germline pathogenic variants
Semanti Mukherjee et al.
CANCER CELL (2022)
Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Carcinogenicity Assessment of Daprodustat (GSK1278863), a Hypoxia-Inducible Factor (HIF)-Prolyl Hydroxylase Inhibitor
David F. Adams et al.
TOXICOLOGIC PATHOLOGY (2020)
Prolyl-hydroxylase inhibitors reconstitute tumor blood vessels in mice
Shunji Nishide et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2020)
PHD2 exerts anti-cancer and anti-inflammatory effects in colon cancer xenografts mice via attenuating NF-κB activity
Li Wang et al.
LIFE SCIENCES (2020)
Secreted Pyruvate Kinase M2 Promotes Lung Cancer Metastasis through Activating the Integrin Beta1/FAK Signaling Pathway
Caihong Wang et al.
CELL REPORTS (2020)
HIF-1 stabilization exerts anticancer effects in breast cancer cells in vitro and in vivo
Neli Kachamakova-Trojanowska et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
David S. Hong et al.
BRITISH JOURNAL OF CANCER (2020)
Hypoxia, Inflammation and Necrosis as Determinants of Glioblastoma Cancer Stem Cells Progression
Marco Papale et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cancer Stem Cells in Pheochromocytoma and Paraganglioma
Laura D. Scriba et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Got glycogen? An energy resource in HIF-mediated prevention of ischemic kidney injury
Volker H. Haase
KIDNEY INTERNATIONAL (2020)
SOD3 induces a HIF-2 alpha-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells
Lorena Carmona-Rodriguez et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Innate Immune Training of Granulopoiesis Promotes Anti-tumor Activity
Lydia Kalafati et al.
CELL (2020)
Metabolism of immune cells in cancer
Robert D. Leone et al.
NATURE REVIEWS CANCER (2020)
The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression
Peter Vaupel et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2019)
Lipid metabolism in cancer cells under metabolic stress
Rimsha Munir et al.
BRITISH JOURNAL OF CANCER (2019)
The Pro-Oncogenic Adaptor CIN85 Acts as an Inhibitory Binding Partner of Hypoxia-Inducible Factor Prolyl Hydroxylase 2
Nina Kozlova et al.
CANCER RESEARCH (2019)
Systemic silencing of Phd2 causes reversible immune regulatory dysfunction
Atsushi Yamamoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
The pro-angiogenic role of hypoxia inducible factor stabilizer FG-4592 and its application in an in vivo tissue engineering chamber model
Muran Zhou et al.
SCIENTIFIC REPORTS (2019)
The Metabolic Signature of Macrophage Responses
Antonella Viola et al.
FRONTIERS IN IMMUNOLOGY (2019)
Intricacies of the Molecular Machinery of Catecholamine Biosynthesis and Secretion by Chromaffin Cells of the Normal Adrenal Medulla and in Pheochromocytoma and Paraganglioma
Annika M. A. Berends et al.
CANCERS (2019)
Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity
Xiao-Guang Yang et al.
FRONTIERS IN ONCOLOGY (2019)
Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
Christopher Groth et al.
BRITISH JOURNAL OF CANCER (2019)
A redox ruthenium compound directly targets PHD2 and inhibits the HIF1 pathway to reduce tumor angiogenesis independently of p53
Vania Vidimar et al.
CANCER LETTERS (2019)
Hypoxia-Modified Cancer Cell Metabolism
Wafaa Al Tameemi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Controlling the Phenotype of Tumor-Infiltrating Macrophages via the PHD-HIF Axis Inhibits Tumor Growth in a Mouse Model (vol 19, pg 940, 2019)
Shunji Nishide et al.
ISCIENCE (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target
Marcin Serocki et al.
ANGIOGENESIS (2018)
PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGF alpha
Higinio Dopeso et al.
CANCER RESEARCH (2018)
The Factor Inhibiting HIF Asparaginyl Hydroxylase Regulates Oxidative Metabolism and Accelerates Metabolic Adaptation to Hypoxia
Jingwei Sim et al.
CELL METABOLISM (2018)
Discovery of Molidustat (BAY85-3934): A Small-Molecule Oral HIF-Prolyl Hydroxylase (HIF-PH) Inhibitor for the Treatment of Renal Anemia
Hartmut Beck et al.
CHEMMEDCHEM (2018)
Cancer stem cells and hypoxia-inducible factors (Review)
Wei-Wei Tong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
HIF-1 a represses the expression of the angiogenesis inhibitor thrombospondin-2
Susan C. MacLauchlan et al.
MATRIX BIOLOGY (2018)
Differential but Complementary HIF1 alpha and HIF2 alpha Transcriptional Regulation
Nicholas L. Downes et al.
MOLECULAR THERAPY (2018)
HIF-1α promotes ZEB1 expression and EMT in a human bladder cancer lung metastasis animal model
Jianning Zhu et al.
ONCOLOGY LETTERS (2018)
SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α
Emilia Mira et al.
NATURE COMMUNICATIONS (2018)
Adipocyte-Derived Lipids Mediate Melanoma Progression via FATP Proteins
Maomao Zhang et al.
CANCER DISCOVERY (2018)
Hypoxia-Driven immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational immunotherapy
Yiliang Li et al.
FRONTIERS IN IMMUNOLOGY (2018)
Identification and validation of a tumor-infiltrating Treg transcriptional signature conserved across species and tumor types
Angela M. Magnuson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging
Rami Alrezk et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
PHD3 Acts as Tumor Suppressor in Mouse Osteosarcoma and Influences Tumor Vascularization via PDGF-C Signaling
Antje Egners et al.
CANCERS (2018)
Overview on Clinical Relevance of Intra-Tumor Heterogeneity
Giorgio Stanta et al.
FRONTIERS IN MEDICINE (2018)
The hypoxic tumor microenvironment in vivo selects the cancer stem cell fate of breast cancer cells
Hoon Kim et al.
BREAST CANCER RESEARCH (2018)
Arg1 expression defines immunosuppressive subsets of tumor-associated macrophages
Sean P. Arlauckas et al.
THERANOSTICS (2018)
PHD2 Is a Regulator for Glycolytic Reprogramming in Macrophages
Annemarie Guentsch et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
Targeting metastasis-initiating cells through the fatty acid receptor CD36
Gloria Pascual et al.
NATURE (2017)
Hypoxia-inducible factor prolyl hydroxylase 2 (PHD2) is a direct regulator of epidermal growth factor receptor (EGFR) signaling in breast cancer
Nina Kozlova et al.
ONCOTARGET (2017)
EglN2 contributes to triple negative breast tumorigenesis by functioning as a substrate for the FBW7 tumor suppressor
Mamoru Takada et al.
ONCOTARGET (2017)
Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells
Huihui Li et al.
GASTROENTEROLOGY (2017)
Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer
Muhammad Tariq et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Discovery and Preclinical Characterization of GSK1278863 (Daprodustat), a Small Molecule Hypoxia Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemias
Jennifer L. Ariazi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
PHD3 affects gastric cancer progression by negatively regulating HIF1A
Ying-Jie Xia et al.
MOLECULAR MEDICINE REPORTS (2017)
Cancer stem cells revisited
Eduard Batlle et al.
NATURE MEDICINE (2017)
Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells
Nicole Colwell et al.
NEURO-ONCOLOGY (2017)
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials
Tzu-Lan Yeh et al.
CHEMICAL SCIENCE (2017)
Synergistic IL-6 and IL-8 paracrine signalling pathway infers a strategy to inhibit tumour cell migration
Hasini Jayatilaka et al.
NATURE COMMUNICATIONS (2017)
Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment
Azharuddin Sajid Syed Khaja et al.
ONCOTARGET (2017)
Tumour blood vessel normalisation by prolyl hydroxylase inhibitor repaired sensitivity to chemotherapy in a tumour mouse model
Satoshi Koyama et al.
SCIENTIFIC REPORTS (2017)
PHD2 Targeting Overcomes Breast Cancer Cell Death upon Glucose Starvation in a PP2A/B55α-Mediated Manner
Giusy Di Conza et al.
CELL REPORTS (2017)
CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells
Elinn Johansson et al.
CELL REPORTS (2017)
The mTOR and PP2A Pathways Regulate PHD2 Phosphorylation to Fine-Tune HIF1α Levels and Colorectal Cancer Cell Survival under Hypoxia
Giusy Di Conza et al.
CELL REPORTS (2017)
Novel Elements of Immune Suppression within the Tumor Microenvironment
Devikala Gurusamy et al.
CANCER IMMUNOLOGY RESEARCH (2017)
The role of hypoxia on the acquisition of epithelial-mesenchymal transition and cancer stemness: a possible link to epigenetic regulation
Chang Dong Yeo et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2017)
Hypoxic Stress-Induced Tumor and Immune Plasticity, Suppression, and Impact on Tumor Heterogeneity
Stephane Terry et al.
FRONTIERS IN IMMUNOLOGY (2017)
Tumor Acidosis and Hypoxia Differently Modulate the Inflammatory Program: Measurements In Vitro and In Vivo
Anne Riemann et al.
NEOPLASIA (2017)
Metabolic Cooperation and Competition in the Tumor Microenvironment: implications for Therapy
Seema Gupta et al.
FRONTIERS IN ONCOLOGY (2017)
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD
Nupur Gupta et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2017)
Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancer
Todd W. Seeley et al.
HYPOXIA (2017)
Tumor suppressor SPOP ubiquitinates and degrades Eg1N2 to compromise growth of prostate cancer cells
Linli Zhang et al.
CANCER LETTERS (2017)
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
Lauren Fishbein et al.
CANCER CELL (2017)
Hypoxia-Inducible Factor-1: A Critical Player in the Survival Strategy of Stressed Cells
Shuyang Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
EMT, cell plasticity and metastasis
Christine L. Chaffer et al.
CANCER AND METASTASIS REVIEWS (2016)
Hypoxia Pathway Mutations in Pheochromocytomas and Paragangliomas
Diana Amorim-Pires et al.
CYTOGENETIC AND GENOME RESEARCH (2016)
Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26
David Kung-Chun Chiu et al.
HEPATOLOGY (2016)
Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal
Kelly L. Singel et al.
IMMUNOLOGICAL REVIEWS (2016)
Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy
Christos E. Zois et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease
Pablo E. Pergola et al.
KIDNEY INTERNATIONAL (2016)
Prolyl hydroxylase 3 (PHD3) expression augments the development of regulatory T cells
Yogesh Singh et al.
MOLECULAR IMMUNOLOGY (2016)
Targeting renal cell carcinoma with a HIF-2 antagonist
Wenfang Chen et al.
NATURE (2016)
Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells
Katrin Moses et al.
SEMINARS IN IMMUNOLOGY (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis
Ching-Wen Lin et al.
NATURE COMMUNICATIONS (2016)
Analysis of angiogenesis related factors in glioblastoma, peritumoral tissue and their derived cancer stem cells
Alessio D'Alessio et al.
ONCOTARGET (2016)
G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers
Wenbin Li et al.
PROTEIN & CELL (2016)
Tumor-associated neutrophils display a distinct N1 profile following TGFβ modulation: A transcriptomics analysis of pro- vs. antitumor TANs
Merav E. Shaul et al.
ONCOIMMUNOLOGY (2016)
Oxidative Dimerization of PHD2 is Responsible for its Inactivation and Contributes to Metabolic Reprogramming via HIF-1α Activation
Gibok Lee et al.
SCIENTIFIC REPORTS (2016)
PHD2: from hypoxia regulation to disease progression
Ana M. Meneses et al.
HYPOXIA (2016)
Hypoxia-induced autophagy as an additional mechanism in human osteosarcoma radioresistance
Helin Feng et al.
JOURNAL OF BONE ONCOLOGY (2016)
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
Belal Chaudhary et al.
VACCINES (2016)
Regulation of cell proliferation by hypoxia-inducible factors
Maimon E. Hubbi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2015)
Immunohistochemical expression of stem cell markers in pheochromocytomas/paragangliomas is associated with SDHx mutations
L. Oudijk et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Confocal Imaging-Guided Laser Ablation of Basal Cell Carcinomas: An Ex Vivo Study
Heidy Sierra et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment
Qian-Qian Zhang et al.
SCIENTIFIC REPORTS (2015)
Metabolic Reprogramming of Cancer-Associated Fibroblasts by IDH3α Downregulation
Daoxiang Zhang et al.
CELL REPORTS (2015)
HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer
Wenjing Zhang et al.
PLOS ONE (2015)
Network Integration of Parallel Metabolic and Transcriptional Data Reveals Metabolic Modules that Regulate Macrophage Polarization
Abhishek K. Jha et al.
IMMUNITY (2015)
A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
Ivraym B. Barsoum et al.
CANCER RESEARCH (2014)
Mechanisms of Hypoxia-Mediated Immune Escape in Cancer
Ivraym B. Barsoum et al.
CANCER RESEARCH (2014)
Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours
V. H. M. Tsang et al.
ENDOCRINE-RELATED CANCER (2014)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray et al.
IMMUNITY (2014)
Exploring the Competition between Proliferative and Invasive Cancer Phenotypes in a Continuous Spatial Model
Eleftheria Tzamali et al.
PLOS ONE (2014)
Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity
Patricia L. M. Dahia
NATURE REVIEWS CANCER (2014)
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
Gregg L. Semenza
Annual Review of Pathology-Mechanisms of Disease (2013)
HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis
Kristin Franke et al.
BLOOD (2013)
Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer
Yung-Chang Lin et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The role of tumor-associated macrophages in breast cancer progression
Elias Obeid et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Regulation of intracellular pH in cancer cell lines under normoxia and hypoxia
Alzbeta Hulikova et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma
Felipe R. Lorenzo et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
The effect of interstitial pressure on tumor growth: Coupling with the blood and lymphatic vascular systems
Min Wu et al.
JOURNAL OF THEORETICAL BIOLOGY (2013)
Vascular Permeability and Drug Delivery in Cancers
Sandy Azzi et al.
FRONTIERS IN ONCOLOGY (2013)
The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness
Bin Bao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2012)
HIF prolyl hydroxylase-2 inhibition diminishes tumor growth through matrix metalloproteinase-induced TGFβ activation
Anne Klotzsche-von Ameln et al.
CANCER BIOLOGY & THERAPY (2012)
Gene-Targeting of Phd2 Improves Tumor Response to Chemotherapy and Prevents Side-Toxicity
Rodrigo Leite de Oliveira et al.
CANCER CELL (2012)
Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth Connecting TGF-β signaling with Warburg-like cancer metabolism and L-lactate production
Carmela Guido et al.
CELL CYCLE (2012)
Somatic HIF2A Gain-of-Function Mutations in Paraganglioma with Polycythemia
Zhengping Zhuang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Hypoxia-Induced Autophagy Confers Resistance of Breast Cancer Cells to Ionizing Radiation
Wen-Shan He et al.
ONCOLOGY RESEARCH (2012)
Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa
Eric T. Clambey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels
Hiroshi Harada et al.
NATURE COMMUNICATIONS (2012)
Loss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancy
Chin-Chih Lin et al.
SCIENTIFIC REPORTS (2012)
Hypoxia-regulated target genes implicated in tumor metastasis
Ya-Ping Tsai et al.
JOURNAL OF BIOMEDICAL SCIENCE (2012)
Inhibition of HIF Prolyl Hydroxylase-2 Blocks Tumor Growth in Mice through the Antiproliferative Activity of TGFβ
Anne Klotzsche-von Ameln et al.
CANCER RESEARCH (2011)
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Eric V. Dang et al.
CELL (2011)
Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
Nadine Rohwer et al.
DRUG RESISTANCE UPDATES (2011)
Endothelial nitric oxide synthase controls the expression of the angiogenesis inhibitor thrombospondin 2
Susan MacLauchlan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF
Erez Feige et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Hypoxia inducible factors in cancer stem cells
J. M. Heddleston et al.
BRITISH JOURNAL OF CANCER (2010)
Differential activation and antagonistic function of HIF-α isoforms in macrophages are essential for NO homeostasis
Norihiko Takeda et al.
GENES & DEVELOPMENT (2010)
Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
Johanna Chiche et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
Cesar A. Corzo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD
Wanja M. Bernhardt et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization
Massimiliano Mazzone et al.
CELL (2009)
Inhibition of Prolyl Hydroxylase Domain Proteins Promotes Therapeutic Revascularization
Celine Loinard et al.
CIRCULATION (2009)
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
A. Soeda et al.
ONCOGENE (2009)
The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas
Judith Favier et al.
PLOS ONE (2009)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
TWIST activation by hypoxia inducible factor-1 (HIF-1)
Muh-Hwa Yang et al.
CELL CYCLE (2008)
Stem cell-related Self-Renewal signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma
Anastasia Murat et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Direct regulation of TWIST by HIF-1α promotes metastasis
Muh-Hwa Yang et al.
NATURE CELL BIOLOGY (2008)
Hypoxic radiosensitization: Adored and ignored
Jens Overgaard
JOURNAL OF CLINICAL ONCOLOGY (2007)
Nitric oxide modulates oxygen sensing by hypoxia-inducible factor 1-dependent induction of prolyl hydroxylase 2
Utta Berchner-Pfannschmidt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail
Andrew J. Evans et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Differential expression of erythropoietin and its receptor in von Hippel-Lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas
TWA Vogel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor
RJ Appelhoff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Hydroxylation of HIF-1: Oxygen sensing at the molecular level
GL Semenza
PHYSIOLOGY (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues
C Murdoch et al.
BLOOD (2004)
Tumor hypoxia: Causative factors, compensatory mechanisms, and cellular response
P Vaupel et al.
ONCOLOGIST (2004)
Oxygen sensing by HIF hydroxylases
CJ Schofield et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules
BJ Moeller et al.
CANCER CELL (2004)
Control of regulatory T cell development by the transcription factor Foxp3
S Hori et al.
SCIENCE (2003)
Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro
TN Ignatova et al.
GLIA (2002)
Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family
KS Hewitson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor
D Lando et al.
GENES & DEVELOPMENT (2002)
Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function
RK Jain
JOURNAL OF CONTROLLED RELEASE (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
分享论文
